Healthcare Facility Licensing in JAFZA: Complete Guide
Free zone status still earns its place for import, re-export and warehousing. It is no longer the only route to full foreign ownership.
Treating patients anywhere in Dubai outside Dubai Healthcare City needs a DHA facility licence, whatever the free zone licence covers. JAFZA licenses the company, the activity, the unit and the visas, and stops there. Much of the life sciences work in the zone never touches a patient, so the guide separates the three models — distribution and storage, manufacturing, and clinical services — and then covers Ministry of Health and Prevention product registration and import permissions, storage logging, batch traceability, recall procedures and control of expired or returned stock. It closes on the question that most often changes the structure: supplying customers on the UAE mainland from a free zone licence.
Two regulators, one facility
Setting up a healthcare or life sciences operation in the Jebel Ali Free Zone means satisfying two separate authorities, and the free zone is only one of them.
JAFZA licenses the company, approves the activity, allocates the unit or warehouse, and sponsors the visas. It does not license clinical practice. Treating patients anywhere in Dubai outside Dubai Healthcare City requires a health facility licence from the Dubai Health Authority (DHA), and every clinician working there needs a DHA professional licence. Companies that read the free zone licence as permission to operate a clinic discover the gap at the first inspection.
The corollary matters too: many life sciences businesses in JAFZA never touch a patient. Distribution, storage, import and export of medicines and medical devices are regulated by the Ministry of Health and Prevention on the product side, and that is a different file from clinical licensing.
Choosing the activity before the premises
JAFZA activity categories separate trading, services, industrial and logistics operations, and the category drives what facility you may take and what the zone will approve. In practice the choice comes down to three models:
- Distribution and storage — a warehouse handling pharmaceuticals, devices or consumables, with temperature-controlled areas where the products require them.
- Manufacturing or assembly — an industrial unit, with the additional environmental, waste and product approvals that follow.
- Clinical or occupational health services — a facility treating patients, which brings the DHA into the file.
Selecting an activity that does not match what the business actually does is not a technicality. It determines the customs treatment of goods, the visa quota, the acceptable premises and whether the health regulators will engage at all.
Premises, fit-out and waste
Once the lease is agreed, fit-out drawings go to JAFZA for approval and then to Civil Defence. Where the operation is clinical, the layout also has to satisfy the health authority's requirements on room specifications, patient flow, separation of clean and contaminated routes and sterilisation. Approving a layout with the landlord and building it before the health regulator has seen it produces rework at the worst possible moment.
Clinical and pharmaceutical waste needs a contract with an approved contractor and a manifest trail. For storage operations, the same discipline applies to expired stock and to returned or recalled product, which cannot simply be disposed of with general waste.
Products: registration, import and storage
Pharmaceuticals and medical devices are registered products. A JAFZA entity importing or holding them needs the relevant Ministry of Health and Prevention registrations and import permissions, and needs to be able to show the chain from arrival to release. The operational obligations that follow are where most enforcement risk sits:
- Storage conditions maintained and logged, with alarms and a documented response when a temperature excursion occurs.
- Batch traceability from receipt through to onward supply.
- A written recall procedure that has been tested, with named responsibility and contactable customers.
- Segregation and control of quarantined, expired and returned stock.
A free zone warehouse is a bonded environment; goods entering the mainland cross a customs border and attract duty and formalities at that point.
Selling into the mainland
This is the question that most often changes the structure. A JAFZA company can hold and export freely, but supplying customers on the UAE mainland generally requires either a mainland-licensed distributor or an appropriately licensed mainland presence of its own. Building a commercial plan around direct mainland sales from a free zone licence is a structural error that surfaces after the lease is signed.
It is also worth testing whether the free zone is the right home at all. Federal Decree-Law No. 26 of 2020, effective 1 June 2021, removed the requirement for 51% UAE-national ownership of mainland limited liability companies, and 100% foreign ownership is now permitted for most mainland activities subject to a strategic-impact list. Free zone status is still valuable for import, re-export and warehousing, but it is no longer the only route to full foreign ownership.
People
Staff are sponsored by the JAFZA entity and employed under the free zone's employment arrangements. Clinical staff need their DHA professional licences in addition, tied to the licensed facility. Visa quota is linked to the size and type of the premises, which is another reason to settle headcount before signing a lease rather than after.
Data
JAFZA is not a common-law financial centre. Unlike the DIFC and ADGM, which operate their own data protection regimes, a JAFZA company handling patient or employee data does so under Federal Decree-Law No. 45 of 2021. Group companies that assume a free zone address puts them outside the federal regime are wrong, and cloud systems hosted abroad, shared service centres and centralised HR platforms all involve transfers that need to be documented.
Tax and reporting
Free zone entities are within the scope of Federal Decree-Law No. 47 of 2022 on corporate tax, which applies to financial years starting on or after 1 June 2023: 0% on taxable income up to AED 375,000 and 9% above that. VAT applies at 5%. The economic substance regime has been cancelled for financial years ending after 31 December 2022 by Cabinet Decision No. 98 of 2024; obligations remain only for the financial years 2019 to 2022, which still matters for entities with open filings from that period.
Common failure points
- Assuming the free zone licence covers clinical activity.
- Fitting out before health authority layout approval.
- Importing product before registration and permits are in place.
- Planning direct mainland sales without a mainland route to market.
- Tracking one renewal date when the zone licence, the facility licence and each professional licence renew separately.
Getting the activity, the premises and the regulator sequence right at the outset avoids the two outcomes that cost most: a fitted-out unit that cannot be licensed, and stock that cannot lawfully be moved. Where a claim does arise from treatment or supply, the traceability and consent records built during setup are what decide medical and product liability disputes.
For advice on a JAFZA healthcare or life sciences setup, product registration, or a licensing problem, contact the Nour Attorneys team.
Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice. Readers should seek professional legal advice tailored to their specific circumstances before making any decisions or taking any action based on the content of this article.
Nour Attorneys Team
Related Resources
Explore more of our insights on related topics:
- Healthcare Facility Licensing Requirements in the UAE
- Medical Malpractice Defense Strategies for Dubai Clinics
- Pharmaceutical Compliance Guidelines for UAE Distributors
- Patient Privacy Regulations for Multinational Entities
